The myofibroblast and its tumours

Journal of Clinical Pathology

Volumn 62, Issue 3, 2009, Pages 236-249

  Eyden, B ^a   Banerjee, S S ^a   Shenjere, P ^a   Fisher, C ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FIBRONECTIN;

BLASTOMA; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL JUNCTION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLINICAL FEATURE; FASCIITIS; FIBROMATOSIS; FIBROSARCOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MYOFIBROBLAST; OSSIFYING MYOSITIS; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER;

DIAGNOSIS, DIFFERENTIAL; FASCIITIS; FIBROBLASTS; FIBROSARCOMA; HUMANS; MYOFIBROMA; SOFT TISSUE NEOPLASMS;

EID: 61849086302     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.061630     Document Type: Review

References (203)

1. Gabbiani G, Ryan GB, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971;27:549-50.
2. Majno G, Gabbiani G, Hirschel BJ, et al. Contraction of granulation tissue in vitro: similarity to smooth muscle. Science 1971;173:548-50.
3. Ryan GB, Cliff WJ, Gabbiani G, et al. Myofibroblasts in human granulation tissue. Hum Pathol 1974;5:55-67.
4. Lipper S, Kahn LB, Reddick RL. The myofibroblast. Pathol Annu 1980;15:409-41.
5. Seemayer TA, Lagace R, Schurch W, et al. The myofibroblast: biologic, pathologic, and theoretical considerations. Pathol Annu 1980;15:443-70.
6. Mentzel T, Fletcher CDM. The emerging role of myofibroblasts in soft tissue neoplasia. Am J Clin Pathol 1997;107:2-5.
7. Eyden BP. Brief review of the fibronexus and its significance for myofibroblastic differentiation and tumor diagnosis. Ultrastruct Pathol 1993;17:611-22.
8. Gabbiani G. The cellular derivation and the life span of the myofibroblast. Patho Res Pract 1996;192:708-11.
9. Schürch W, Seemayer TA, Gabbiani G. The myofibroblast. A quarter century after its discovery. Am J Surg Pathol 1998;22:141-7.
10. Eyden B. The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct Pathol 2001;25:39-50.
11. Tomasek JJ, Gabbiani G, Hinz B, et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nature Rev Mol Cell Biol 2002;3:349-63.
12. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Patho 2003;200:500-3.
13. Desmouliere A, Guyot C, Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 2004;48:509-17.
14. Eyden B. The myofibroblast. A study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. Siena: Nuova Immagine Editrice, 2007.
15. SchUrch W, Seemayer TA, Hinz B, et al. Myofibroblast. In: Mills SE, ed. Histology for pathologists, 3rd edn. Philadelphia, PA: Lippincott, Williams & Wilkins, 2007:123-64.
16. Eyden B. The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 2008;12:22-37.
17. Watanabe K, Tajino T, Sekiguchi M, et al. h-caldesmon as a specific marker for smooth muscle tumors. Comparison with other smooth muscle markers in bone tumors. Am J Clin Pathol 2000;113:663-8.
18. + fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Arch 2004;444:231-4.
19. Truong LD, Rangdaeng S, Cagle P, et al. The diagnostic utility of desmin. A study of 584 cases and review of the literature. Am J Clin Pathol 1990;93:305-14.
20. van der Loop FTL, Schaart G, Timmer EDJ, et al. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol 1996;134:401-11.
21. Eyden B. Smooth-muscle-type myofilaments and actin in reactive and neoplastic nonmuscle cells. Ultrastruct Pathol 2000;24:347-52.
22. O'Shea JD. An ultrastructural study of smooth muscle-like cells in the theca externa of ovarian follicles in the rat. Anat Rec 1970;167:127-40.
23. Bressler RS. Myoid cells in the capsule of the adrenal gland and in monolayers derived from cultured adrenal capsules. Anat Rec 1973;177:525-32.
24. Rossouw DJ, Chase CC. infrastructure of the capsule of the rabbit adrenal gland. Acta Anat 1978;100:538-14.
25. Wiseman OJ, Fowler CJ, Landon DN. The role of the human bladder lamina propria myofibroblast. BJU Int 2003;91:89-93.
26. Beertsen W. Migration of fibroblasts in the periodontal ligament of the mouse incisor as revealed by autoradiography. Arch Oral Biol 1975;20:659-66.
27. Garant PR. Collagen resorption by fibroblasts. A theory of fibroblastic maintenance of the periodontal ligament. J Periodont 1976;47:380-90.
28. Holstein AF, Maekawa M, Nagano T, et al. Myofibroblasts in the lamina propria of human seminiferous tubules are dynamic structures of heterogeneous phenotype. Arch Histol Cytol 1996;59:109-25.
29. Desmoulière A, Redard M, Darby I, et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
30. Rønnov-Jessen L, Petersen OW, Koteliansky VE, et al. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 1995;95:859-73.
31. Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007;13:952-61.
32. Yen T-H, Wright NA. The gastrointestinal tract stem cell niche. Stem Cell Rev 2006;2:203-12.
33. Jabs A, Moncada GA, Nichols CE, et al. Peripheral blood mononuclear cells acquire myofibroblastic characteristics in granulation tissue. J Vasc Res 2005;42:174-80.
34. Yamaguchi Y, Kubo T, Murakami T, et al. Bone marrow cells differentiate into wound myofibroblasts and accelerate the healing of wounds with exposed bones when combined with an occlusive dressing. Br J Dermatol 2005;152:616-22.
35. Spees JL, Whitney MJ, Sullivan DE, et al. Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension. FASEB J 2008;22:1226-36.
36. Wang G, Bunnell BA, Painter RG, et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Nat Acad Sci 2005;102:186-91.
37. Kisseleva T, Uchinami H, Feirt N, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006;45:429-38.
38. Endo J, Sano M, Fujita J, et al. Bone marrow-derived cells are involved in the pathogenesis of cardiac hypertrophy in response to pressure overload. Circulation 2007;116:1176-84.
39. Miollmann H, Nef HM, Kostin S, et al. Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res 2006;71:661-71.
40. Fujita J, Mori M, Kawada H, et al. Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. Stem Cells 2007;25:2750-9.
41. van Amerongen MJ, Bou-Gharios G, Popa ER, et al. Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J Pathol 2008;214:377-86.
42. Xu Q, Zhang Z, Davison F, et al. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 2003;93:e76-86.
43. Ishii G, Sangai T, Oda T, et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun 2003;309:232-40.
44. Nguyen TQ, Chon H, van Nieuwenhoven FA, et al. Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling? Diabetologia 2006;49:1039-18.
45. Direkze NC, Hodivala-Dilke K, Jeffery R, et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 2004;64:8492-5.
46. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003;112:1776-84.
47. Willis BC, du Bois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 2006;3:377-82.
48. Guarino M, Rubino B, Ballabio G. The role of epithelial- mesenchymal transition in cancer pathology. Pathology 2007;39:305-18.
49. Radisky DC, Kenny PA, Bissell MJ. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem 2007;101:830-9.
50. Ng Y-Y, Huang T-P, Yang W-C, et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998;54:864-76.
51. Ng Y-Y, Fan J-M, Mu W, et al. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant 1999;14:2860-72.
52. Tremblay G. Stromal aspects of breast carcinoma. Exp Mol Pathol 1979;31:248-60.
53. Seemayer TA, Lagace R, Schurch W, et al. Myofibroblasts in the stroma of invasive and metastatic carcinoma. A possible host response to neoplasia. Am J Surg Pathol 1979;3:525-33.
54. Hinz B, Gabbiani G. Mechanisms of force generation and transmission by myofibroblasts. Curr Opin Biotechnol 2003;14:538- 46.
55. Kellerman MG, Sobral LM, da Silva SD, et al. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 2007;51:849-53.
56. Surowiak P, Murawa D, Materna V, et al. Occurrence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor. Anticancer Res 2007;27:2917-24.
57. Baglole CJ, Ray DM, Bernstein SH, et al. More than structured cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol Invest 2006;35:297-325.
58. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-7.
59. Nielsen BS, Sehested M, Duun S, et al. Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer. Lab Invest 2001;81:1485-501.
60. Schor SL, Ellis IR, Jones SJ, et al. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells. Cancer Ras 2003;63:8827-36.
61. Orimo A, Weinberg RA. Stromal fibroblasts in cancer. A novel tumor-promoting cell type. Call Cycle 2006;5:1597-601.
62. Harris M, Ahmed A. The ultrastructure of tubular carcinoma of the breast. J Pathol 1977;123:79-83.
63. Dominguez-Malagón H. Intracellular collagen and fibronexus in fibromatosis and other fibroblastic tumors. Ultrastruct Pathol 2004;28:67-73.
64. Konwaler BE, Keasbey L, Kaplan L. Subcutaneous pseudosarcomatous fibromatoses (fasciitis). Am J Clin Pathol 1955;25:241-52.
65. Hutter RV, Stewart FW, Foote FW Jr. Fasciitis. A report of 70 cases with follow-up proving the benignity of the lesion. Cancer 1962;15:992-1003.
66. Bernstein KE, Lattes R. Nodular (pseudosarcomatous) fasciitis, a nonrecurrent lesion: clinicopathologic study of 134 cases. Cancer 1982;49:1668-78.
67. Shimizu S, Hashimoto H, Enjoji M. Nodular fasciitis: an analysis of 250 patients. Pathology 1984;16:161-6.
68. Montgomery EA, Meis JM. Nodular fasciitis. Its morphologic spectrum and immunohistochemical profile. Am J Surg Pathol 1991;15:942-8.
69. Kern WH. Proliferative myositis; a pseudosarcomatous reaction to injury: a report of seven cases. Arch Pathol 1960;69:209-16.
70. Enzinger FM, Dulcey F. Proliferative myositis: report of thirty-three cases. Cancer 1967;20:2213-23.
71. Meis JM, Enzinger FM. Proliferative fasciitis and myositis of childhood. Am J Surg Pathol 1992;16:364-72.
72. El-Jabbour JN, Bennett MH, Burke MM, et al. Proliferative myositis. An immunohistochemical and ultrastructural study. Am J Surg Pathol 1991;15:654-9.
73. Ackerman LV. Extra-osseous localized non-neoplastic bone and cartilage formation (so-called myositis ossificans): clinical and pathological confusion with malignant neoplasma. J Bone Joint Surg 1958;40A:279-98.
74. Kilpatrick SE, Koplyay P, Pope TL, et al. Clinical, radiologic, and pathologic spectrum of myositis ossificans and related lesions: a unifying concept. Adv Anat Pathol 1997;4:277-86.
75. Montgomery EA, Meis JM, Mitchell MS, et al. Atypical decubital fibroplasia. A distinctive fibroblastic pseudotumor occurring in debilitated patients Am J Surg Pathol 1992;16:708-15.
76. Perosio PM, Weiss SW. Ischemic fasciitis: a juxta-skeletal fibroblastic proliferation with a predilection for elderly patients. Mod Pathol 1993;6:69-72.
77. Fukunaga M. Atypical decubital fibroplasia with unusual histology. APMIS 2001;109:631-5.
78. Hollowood K, Fletcher CD. Pseudosarcomatous myofibroblastic proliferations of the spermatic cord (''proliferative funiculitis"). Histologic and immunohistochemical analysis of a distinctive entity. Am J Surg Pathol 1992;16:448-54.
79. Michal M, Hes 0, Kazakov DV. Mesothelial glandular structures within pseudosarcomatous proliferative funiculitis-a diagnostic pitfall: report of 17 cases. Int J Surg Pathol 2008;16:48-56.
80. Chung EB, Enzinger FM. Infantile myofibromatosis. Cancer 1981;48:1807-18.
81. Bracko M, Cindro L, Golouh R. Familial occurrence of infantile myofibromatosis. Cancer 1992;69:1294-9.
82. Smith KJ, Skelton HG, Barrett TL, et al. Cutaneous myofibroma. Mod Pathol 1989;2:603-9.
83. Daimaru Y, Hashimoto H, Enjoji M. Myofibromatosis in adults (adult counterpart of infantile myofibromatosis). Am J Surg Pathol 1989;13:859-65.
84. Ng TL, Gown AM, Barry TS, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 2005;18:68-74.
85. Montgomery E, Torbenson MS, Kaushal M, et al. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol 2002;26:1296-1301.
86. Kamino H, Reddy VB, Gero M, et al. Dermatomyofibroma. A benign cutaneous, plaque-like proliferation of fibroblasts and myofibroblasts in young adults. J Cutan Pathol 1992;19:85-93.
87. Mentzel T, Calonje E, Fletcher CDM. Dermatomyofibroma: additional observations on a distinctive cutaneous myofibroblastic tumour with emphasis on differential diagnosis. Br J Dermatol 1993;129:69-73.
88. Eyden BP, Shanks JH, Ioachim E, et al. Myofibroblastoma of breast: evidence favoring smooth-muscle rather than myofibroblastic differentiation. Ultrastruct Pathol 1999;23:249-57.
89. Pauwels P, Sciot R, Croiset F, et al. Myofibroblastoma of the breast: genetic link with spindle cell lipoma. J Pathol 2000;191:282-5.
90. Eyden BP, Harris M, Greywoode GI, et al. Intranodal myofibroblastoma: report of a case. Ultrastruct Pathol 1996;20:79-88.
91. Laskin WB, Fetsch JF, Tavassoli FA. Superficial cervicovaginal myofibroblastoma: fourteen cases of a distinctive mesenchymal tumor arising from the specialized subepithelial stroma of the lower female genital tract. Hum Pathol 2001;32:715-25.
92. Ganesan R, McCluggage WG, Hirschowitz L, et al. Superficial myofibroblastoma of the lower female genital tract: report of a series including tumours with a vulval location. Histopathology 2005;46:137-13.
93. Stewart CJ, Amanuel B, Brennan BA, et al. Superficial cervico-vaginal myofibroblastoma: a report of five cases. Pathology 2005;37:144-8.
94. Zamecník M, Michal M. Angiomyofibroblastoma of the lower genital tract in women. Cesk Patol 1994;30:16-8.
95. Fletcher CDM, Tsang WYW, Fisher C, et al. Angiomyofibroblastoma of the vulva. A benign neoplasm distinct from aggressive angiomyxoma. Am J Surg Pathol 1992;16:373-82.
96. Nielsen GP, Rosenberg AE, Young RH, et al. Angiomyofibroblastoma of the vulva and vagina. Mod Pathol 1996;9:284-91.
97. Ghadially FN. Diagnostic electron microscopy of tumours. London and Boston: Butterworths, 1980.
98. Fisher C. Myofibroblastic malignancies. Adv Anat Pathol 2004;11 :190-201.
99. Fisher C. Myofibrosarcoma. Virchows Arch 2004;445:215-23.
100. Vasudev KS, Harris M. A sarcoma of myofibroblasts. An ultrastructural study. Arch Pathol Lab Med 1978;102:185-8.
101. Mentzel T, Dry S, Katenkamp D, et al. Low-grade myofibroblastic sarcoma. Analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol 1998;22:1228-38.
102. Montgomery E, Goldblum JR, Fisher C. Myofibrosarcoma: a clinicopathologic study. Am J Surg Pathol 2001;25:219-28.
103. Meng GZ, Zhang HY, Bu H, et al. Myofibroblastic sarcomas: a clinicopathological study of 20 cases. Chin Med J (Engl) 2007;120:363-9.
104. Agaimy A, Wiinsch PH, Schroeder J, et al. Low-grade abdominopelvic sarcoma with myofibroblastic features (low-grade myofibroblastic sarcoma): clinicopathological, immunohistochemical, molecular genetic and ultrastructural study of two cases with literature review. J Clin Pathol 2008;61:301-6.
105. Bisceglia M, Tricarico N, Minenna P, et al. Myofibrosarcoma of the upper jawbones: a clinicopathologic and ultrastructural study of two cases. Ultrastruct Pathol 2001;25:385-97.
106. Smith DM, Mahmoud HH, Jenkins JJ 3rd, et al. Myofibrosarcoma of the head and neck in children. Pediatr Pathol Lab Med 1995;15:403-18.
107. Watanabe K, Ogura G, Tajino T, et al. Myofibrosarcoma of the bone. A clinicopathologic study. Am J Surg Pathol 2001;25:1501-7.
108. Kuhnen C, Homann HH, Mentzel T. [Myofibroblastic sarcoma of the thoracic wall. Change in appearance in tumour recurrence]. Pathologe 2003;24:128-35.
109. Eyden BP, Christensen L. Leiomyosarcoma versus myofibrosarcoma: observations and terminology. Ultrastruct Pathol 1993;17:231-9.
110. Carlson JW, Fletcher CDM. Immunohistochemistry for β-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology 2007;51:509-14.
111. Watanabe K, Tanaka M, Takashi K, et al. Fibronexus in low-grade myofibrosarcoma: a case report. Ultrastruct Pathol 2008;32:97-100.
112. Mentzel T. Myofibroblastic sarcomas: a brief review of sarcomas showing a myofibroblastic line of differentiation and discussion of the differential diagnosis. Curr Diagn Pathol 2001;7:17-24.
113. Lestou VS, 0'Connell JX, Ludkovski 0, et al. Coamplification of 12p11 and 12q13-q22 in multiple ring chromosomes in a spindle cell sarcoma resolved by novel multicolor fluorescence in situ hybridization analysis. Cancer Genet Cytogenet 2002;139:44-7.
114. Keller C, Gibbs CN, Kelly SM, et al. Low-grade myofibrosarcoma of the head and neck: importance of surgical therapy. J Pediatr Hematol Oncol 2004;26:119-20.
115. Eyden B. Electron microscopy in the study of myofibroblastic lesions. Semin Diagn Pathol 2003;20:13-24.
116. Crocker DJ, Murad TM. Ultrastructure of fibrosarcoma in a male breast. Cancer 1969;23:891-9.
117. Dickersin GR. Diagnostic electron microscopy: a textlatlas. New York: Igaku-Shoin, 1988.
118. Eyden B. The fibronexus in reactive and tumoral myofibroblasts: further characterisation by electron microscopy. Histol Histopathol 2001;16:57-70.
119. Dobashi Y, Noguchi T, Nasuno S, et al. Hyalinizing spindle cell tumor with giant rosettes: report of a case showing remarkable myofibroblastic differentiation. Pathol Res Pract 2001;197:691-7.
120. Montgomery E, Fisher C. Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study. Histopathology 2001;38:499-509.
121. Massi D, Beltrami G, Capanna R, et al. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance. Eur J Surg Oncol 2004;30:1131-6.
122. Deyrup AT, Haydon RC, Huo D, et al. Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: an analysis of 92 cases. Cancer 2003;98:805-13.
123. Gonzalez FA, Vazquez AC, Uscanga CC, et al. Pleomorphic myofibrosarcoma of the tibia with aneuploid DNA content. Ann Diagn Pathol 2007;11 :340-4.
124. Coindre JM, Mariani 0, Chibon F, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol 2003;16:256-62.
125. Franchi A, Massi D, Santucci M. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas. Ultrastruct Pathol 2005;29:295-304.
126. Fu YS, Gabbiani G, Kaye GI, et al. Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytomas): general considerations and electron microscopic and tissue culture studies. Cancer 1975;35:176-98.
127. Fisher C. The value of electronmicroscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: a study of 200 cases. Histopathology 1990;16:441-54.
128. Hirose T, Kudo E, Hasegawa T, et al. Expression of intermediate filaments in malignant fibrous histiocytomas. Hum Pathol 1989;20:871-7.
129. Churg AM, Kahn LB. Myofibroblasts and related cells in malignant fibrous and fibrohistiocytic tumors. Hum Pathol 1977;8:205-18.
130. Harris M. The ultrastructure of benign and malignant fibrous histiocytomas. Histopathology 1980;4:29-44.
131. Fukuda T, Tsuneyoshi M, Enjoji M. Malignant fibrous histiocytoma of soft parts: an ultrastructural quantitative study. Ultrastruct Pathol 1988;12:117-29.
132. Watanabe K, Ogura G. Fibronexus in ''malignant fibrous histiocytoma'' of the bone: a case report of pleomorphic myofibrosarcoma. Ultrastruct Pathol 2002;26:47-51.
133. Hasegawa T, Hasegawa F, Hirose T, et al. Expression of smooth muscle markers in so called malignant fibrous histiocytomas. J Clin Pathol 2003;56:666-71.
134. Lawson CW, Fisher C, Gatter KC. An immunohistochemical study of differentiation in malignant fibrous histiocytoma. Histopathology 1987;11:375-83.
135. Schurch W, Begin LR,SeemayerTA, et al. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s. Am J Surg Pathol 1996;20:131-17.
136. Fletcher CDM, Gustafson P, Rydholm A, et al. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 2001;19:3045-50.
137. Oda Y, Miyajima K, Kawaguchi K, et al. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am J Surg Pathol 2001;25:1030-8.
138. Downes KA, Goldblum JR, Montgomery EA, et al. Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases. Mod Pathol 2001;14:179-84.
139. Lee YF, John M, Edwards S, et al. Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling. Br J Cancer 2003;88:510-5.
140. Coffin CM, Humphrey PA, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol 1998;15:85-101.
141. Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol 1991;15:1146-56.
142. Fletcher CDM, inni KK, Mertens F, eds. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002.
143. Qiu X, Montgomery E, Sun B. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Hum Pathol 2008;39:846-56.
144. Nonaka D, Birbe R, Rosai J. So-called inflammatory myofibroblastic tumour: a proliferative lesion of fibroblastic reticulum cells? Histopathology 2005;46:604-13.
145. Coffin CM, Watterson J, Priest JR, et al. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995;19:859-72.
146. Coffin CM, Dehner LP, Meis-Kindblom JM. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol 1998;15:102-10.
147. Wenig BM, Devaney K, Bisceglia M. Inflammatory myofibroblastic tumor of the larynx. A clinicopathologic study of eight cases simulating a malignant spindle cell neoplasm. Cancer 1995;76:2217-29.
148. Montgomery EA, Shuster DD, Burkart AL, et al. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol 2006;30:1502-12.
149. Hirsch MS, Dal Cin P, Fletcher CDM. ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tract. Histopathology 2006;48:569-78.
150. Harik LR, Merino C, Coindre JM, et al. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol 2006;30:787-94.
151. Sukov WR, Cheville JC, Carlson AW, et al. itility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Mod Pathol 2007;20:592-603.
152. Mirra M, Falconieri G, Zanconati F, et al. Inflammatory fibrosarcoma: another imitator of Hodgkin's disease? Pathol Res Pract 1996;192:474-82.
153. Meis-Kindblom JM, Kjellstrom C, Kindblom LG. Inflammatory fibrosarcoma: update, reappraisal, and perspective on its place in the spectrum of inflammatory myofibroblastic tumors. Semin Diagn Pathol 1998;15:133-13.
154. Miettinen M. Are desmoid tumors kit positive? Am J Surg Pathol 2001;25:549-50.
155. Yu H, Gibson JA, Pinkus GS, et al. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors. Am J Clin Pathol 2007;128:776-82.
156. Chan JK, Cheuk W, Shimizu M. Anaplastic lymphoma kinase expression in inflammatory pseudotumors. Am J Surg Pathol 2001;25:761-8.
157. Cessna MH, Zhou H, Sanger WG, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol 2002:15;931-8.
158. Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 2001;25:1364-71.
159. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007;31:509-20.
160. Li XQ, Hisaoka M, Shi DR, et al. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases. Hum Pathol 2004;35:711-21.
161. Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000;157:377-84.
162. Bridge JA, Kanamori M, Ma Z, et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol 2001;159:411-5.
163. Kovach SJ, Fischer AC, Katzman PJ, et al. Inflammatory myofibroblastic tumors. J Surg Oncol 2006;94:385-91.
164. Morotti RA, Legman MD, Kerkar N, et al. Pediatric inflammatory myofibroblastic tumor with late metastasis to the lung: case report and review of the literature. Pediatr Dev Pathol 2005;8:224-9.
165. Petridis AK, Hempelmann RG, Hugo HH, et al. Metastatic low-grade inflammatory myofibroblastic tumor (IMT) in the central nervous system of a 29-year-old male patient. Clin Neuropathol 2004;23:158-66.
166. Miyajima N, Koike H, Kawaguchi M, et al. Idiopathic retroperitoneal fibrosis associated with IgG4-positive-plasmacyte infiltrations and idiopathic chronic pancreatitis. Int J Urol 2006;13:1442-1.
167. Taniguchi T, Kobayashi H, Fukui S, et al. A case of multifocal fibrosclerosis involving posterior mediastinal fibrosis, retroperitoneal fibrosis, and a left seminal vesicle with elevated serum IgG4. Hum Pathol 2006;37:1237-9.
168. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, et al. Nuclear β-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005;29:653-9.
169. Chan JK, Fletcher CD, Nayler SJ, et al. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 1997;79:294-313.
170. Grogg KL, Macon WR, Kurtin PJ, et al. A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor. Mod Pathol 2005;18:260-6.
171. Soriano AO, Thompson MA, Admirand JH, et al. Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature. Am J Hematol 2007;82:725-8.
172. Perez-Ordonez B, Erlandson RA, Rosai J. Follicular dendritic cell tumor. Report of 13 additional cases of a distinctive entity. Am J Surg Pathol 1996;20:944-55.
173. Rubin BP. Gastrointestinal stromal tumours: an update. Histopathology 2006;48:83-96.
174. Espinosa I, Lee CH, Kim MK, et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol 2008;32:210-8.
175. Coffin CM, Jaszcz W, O'Shea PA, et al. So-called congenital-infantile fibrosarcoma: does it exist and what is it? Pediatr Pathol 1994;14:133-50.
176. Schofield DE, Fletcher JA, Grier HE, et al. Fibrosarcoma in infants and children. Application of new techniques. Am J Surg Pathol 1994;18:14-24.
177. Gorman PA, Malone M, Pritchard J, et al. Deletion of part of the short arm of chromosome 17 in a congenital fibrosarcoma. Cancer Genet Cytogenet 1990;48:193-8.
178. Strehl S, Ladenstein R, Wrba F, et al. Translocation (12;13) in a case of infantile fibrosarcoma. Cancer Genet Cytogenet 1993;71:94-6.
179. Knezevich SR, McFadden DE, Tao W, et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998;18:184-7.
180. Bourgeois JM, Knezevich SR, Mathers JA, et al. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors. Am J Surg Pathol 2000;24:937-46.
181. Sheng WQ, Hisaoka M, Okamoto S, et al. Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues. Am J Clin Pathol 2001;115:348-55.
182. Rubin BP, Chen CJ, Morgan TW, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol 1998;153:1451-8.
183. O'Malley DP, Mierau GW, Beckwith JB, et al. iltrastructure of cellular congenital mesoblastic nephroma. Ultrastruct Pathol 1996;20:417-27.
184. Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002;2:367-76.
185. Eguchi M, Eguchi-Ishimae M, Tojo A, et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 1999;93:1355-63.
186. Chung EB, Enzinger FM. Infantile fibrosarcoma. Cancer 1976;38:729-39.
187. Soule EH, Pritchard DJ. Fibrosarcoma in infants and children: a review of 110 cases. Cancer 1977;40:1711-21.
188. Alaggio R, Ninfo V, Rosolen A, et al. Primitive myxoid mesenchymal tumor of infancy: a clinicopathologic report of 6 cases. Am J Surg Pathol 2006;30:388-94.
189. Enzinger FM, Zhang RY. Plexiform fibrohistiocytic tumor presenting in children and young adults. An analysis of 65 cases. Am J Surg Pathol 1988;12:818-26.
190. Moosavi C, Jha P, Fanburg-Smith JC. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD. Ann Diagn Pathol 2007;11:313-9.
191. Cho S, Chang SE, Choi JH, et al. Myxoid plexiform fibrohistiocytic tumour. J Eur Acad Dermatol Venereol 2002;16:519-21.
192. Fisher C. Atypical plexiform fibrohistiocytic tumour. Histopathology 1997;30:271-3.
193. Angervall L, Kindblom LG, Lindholm K, et al. Plexiform fibrohistiocytic tumor. Report of a case involving preoperative aspiration cytology and immunohistochemical and ultrastructural analysis of surgical specimens. Pathol Res Pract 1992;188:350-6.
194. Hollowood K, Holley MP, Fletcher CDM. Plexiform fibrohistiocytic tumour: clinicopathological, immunohistochemical and ultrastructural analysis in favour of a myofibroblastic lesion. Histopathology 1991;19:503- 13.
195. Giard F, Bonneau R, Raymond GP. Plexiform fibrohistiocytic tumor. Dermatologica 1991;183:290-3.
196. Remstein ED, Arndt CA, Nascimento AG. Plexiform fibrohistiocytic tumor: clinicopathologic analysis of 22 cases. Am J Surg Pathol 1999;23:662-70.
197. Fisher C. Epithelioid sarcoma: the spectrum of ultrastructural differentiation in seven immunohistochemically defined cases. Hum Pathol 1988;19:265-75.
198. Blewitt RW, Aparicio SG, Bird CC. Epithelioid sarcoma: a tumour of myofibroblasts. Histopathology 1983;7:573-84.
199. Eyden BP, Harris M, Banerjee SS, et al. The ultrastructure of epithelioid sarcoma. J Submicrosc Cytol Pathol 1989;21:281-93.
200. Eyden BP, Banerjee SS, Harris M, et al. A study of spindle cell sarcomas showing myofibroblastic differentiation. Ultrastruct Pathol 1991;15:367-78.
201. Balercia G, Bhan AK, Dickersin GR. Sarcomatoid carcinoma: an ultrastructural study with light microscopic and immunohistochemical correlation of 10 cases from various anatomic sites. Ultrastruct Pathol 1995;19:249-63.
202. Eyden B, Banerjee SS. Spindle-cell squamous carcinoma exhibiting myofibroblastic differentiation. A study of two cases showing fibronexus junctions. Virchows Arch 2002;440:36-44.
203. Miettinen M, Fanburg-Smith JC, Virolainen M, et al. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol 1999;30:934-42.